Reaction
Immune-Mediated Gastritis reporting signals
As of the last recalculation, Immune-Mediated Gastritis appears in 184 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is PEMBROLIZUMAB (PRR 292.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pembrolizumab | 110 | 292.6 | 292.9 |
| Ipilimumab | 31 | 97.5 | 97.6 |
| Nivolumab | 56 | 93.8 | 93.8 |
| Pemetrexed | 12 | 67.7 | 67.7 |
| Pemetrexed Disodium | 14 | 44.9 | 44.9 |